Related Articles
Doest Rheumatoid Arthritis Take a Toll?
Exploring the Toll background
A 52-Year-Old Lupus Paper Remains Important Today
Over 50 years ago, an article appeared in The New England Journal of Medicine: “Immunologic Factors and Clinical Activity in Systemic Lupus Erythematosus.”1 Written by a young postdoctoral fellow, Peter H. Schur, MD, and colleagues, the article synthesized important work in the field at the time. What follows is a discussion of the historical context…
How a Nuclear Molecule Alarms the Immune System
The role of HMGB1 in the pathogenesis of lupus nephritis
Dendritic Cells as Therapeutics: The New Frontier
Cancer treatments, organ transplants and rheumatologic diseases—dendritic cells are being used throughout medicine to create innovative treatments, according to presenters of a virtual session during the European e-Congress of Rheumatology.